Gland Pharma (GLAND) Share Price Rises 2.05% as Stock Gains Today
- September 3, 2026
- Posted by: Kunal Singla
- Category: News
Gland Pharma Share Price opened higher in intraday trade and is trading at Rs 3,295.85, up Rs 66.05 or 2.05% from the previous close of Rs 3,229.80. The market capitalisation is Rs 53,617.37 Cr. According to latest Univest data, the price event is confirmed, but no company-specific catalyst is established.
Gland Pharma Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 3,295.85 |
| Previous Close | Rs 3,229.8 |
| Today's Move | Rs 66.05 (+2.05%) |
| Open | Rs 3,247.7 |
| High | Rs 3,297.35 |
| Low | Rs 3,227.8 |
| Market Capitalisation | Rs 53,617.37 crore |
| Market Cap Category | Large Cap |
For readers tracking Gland Pharma Share Price Today, the move places the stock among Stocks in News and keeps it relevant in Stock Market Today coverage, even though the verified data does not point to a fresh trigger. The stock touched a high of Rs 3,297.35 and a low of Rs 3,227.80, showing a narrow intraday band around the current price. In Gland Pharma Stock News terms, the main story is the price rise itself, together with how valuation and sector benchmarks frame the move. Univest data also shows a P/E of 43.12, a P/B of 4.99, ROE of 10.56% and ROCE of 14.96%, which give the intraday gain a fundamental context. Investors tracking Gland Pharma Share Price can watch how the stock trades against these ratios and the wider pharmaceuticals peer set through the day.
Gland Pharma Ltd. (GLAND) rose to Rs 3,295.85 from the previous close of Rs 3,229.8, a move of Rs 66.05 or 2.05%. The stock opened at Rs 3,247.7, reached a high of Rs 3,297.35, recorded a low of Rs 3,227.8.
Gland Pharma Share Price is higher today by Rs 66.05, or 2.05%, and the stock is trading near the upper end of its intraday range. The move is factual and measurable, with the current price at Rs 3,295.85 versus the previous close of Rs 3,229.80. The day open was Rs 3,247.70, the day high was Rs 3,297.35 and the day low was Rs 3,227.80.
For Gland Pharma Share Price Today, the opening level was above the previous close, and the stock has remained close to the day high through the latest trade. That keeps the Gland Pharma Share Price discussion centred on price action rather than speculation. The market capitalisation of Rs 53,617.37 Cr also places the company in a large market value bracket, which matters when readers compare Gland Pharma Stock Performance with other names in Pharmaceuticals & Drugs. According to latest Univest data, the price event is confirmed, but no company-specific catalyst is established. From here, the more useful question is how the valuation and financial ratios fit the move in Gland Pharma Share Price.
Gland Pharma Ltd. (GLAND) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 53,617.37 crore |
| P/E Ratio | 43.12x |
| P/B Ratio | 4.99x |
| ROE | 10.56% |
| ROCE | 14.96% |
| EPS | Rs 74.89 |
| Book Value Per Share | Rs 647.56 |
| Dividend Yield | 0.62% |
Gland Pharma Ltd. (GLAND) fundamental metrics show P/E 43.12x, P/B 4.99x, ROE 10.56%, ROCE 14.96%. These figures provide context only and are not a buy or sell signal.
Gland Pharma Ltd. has a market capitalisation of Rs 53,617.37 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 43.12x, P/B at 4.99x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 10.56% and ROCE of 14.96%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 74.89, book value per share of Rs 647.56, dividend yield of 0.62%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 30.6x, median ROE of 11.23%, median ROCE of 13.1%. Taken together, they outline the fundamentals rather than a view on the stock.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 43.12x |
| Benchmark Median P/E | 30.6x |
| Benchmark Average P/E | 59.27x |
| Benchmark P/E Range | 2.71x to 1,378.1x |
| Company P/B Ratio | 4.99x |
| Benchmark Median P/B | 2.8x |
| Company ROE | 10.56% |
| Benchmark Median ROE | 11.23% |
| Company ROCE | 14.96% |
| Benchmark Median ROCE | 13.1% |
| Company Market Capitalisation | Rs 53,617.37 crore |
| Benchmark Median Market Cap | Rs 789.58 crore |
Gland Pharma Ltd. (GLAND) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.
Gland Pharma Ltd. (GLAND) has a P/E ratio of 43.12x, which is above the benchmark median of 30.6x, a difference of +40.92%. On its own, the P/E gap is a valuation reference point, not a trading call.
Gland Pharma Ltd. (GLAND) has a ROE of 10.56%, which is below the benchmark median of 11.23%, a difference of -5.97%. Gland Pharma Ltd. (GLAND) has a ROCE of 14.96%, which is above the benchmark median of 13.1%, a difference of +14.2%.
Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA | 4,48,687.64 | 40.96 | 5.03 | 14.85 | 19.11 |
| Divi's Laboratories Ltd. | DIVISLAB | 2,95,080.27 | 87.38 | 16.33 | 16.19 | 21.51 |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM | 1,77,677.43 | 83.06 | 9.6 | 26.76 | 19.27 |
| Laurus Labs Ltd. | LAURUSLABS | 1,26,433.06 | 93.64 | 20.7 | 18.31 | 18.2 |
| Zydus Lifesciences Ltd. | ZYDUSLIFE | 1,19,969.79 | 28.52 | 4.29 | 19.69 | 21.39 |
Gland Pharma Ltd. (GLAND) has a P/E ratio of 43.12x compared with the displayed peer median of 83.06x. This peer read is a relative benchmark rather than a trading signal. Its ROE of 10.56% compares with a peer median of 18.31% across the companies shown in the table. ROCE stood at 14.96% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Gland Pharma Ltd. (GLAND) has a market capitalisation of Rs 53,617.37 crore. All 5 peers shown have a larger market capitalisation.
Why Investors Are Watching Gland Pharma
- Gland Pharma Share Price is rising today, with the stock trading at Rs 3,295.85 and up 2.05% from the previous close.
- The intraday range is tight, with the day high at Rs 3,297.35 and the day low at Rs 3,227.80, which keeps the move easy to track.
- Gland Pharma Fundamental Analysis shows a P/E of 43.12, a P/B of 4.99, ROE of 10.56% and ROCE of 14.96%.
- The company’s market capitalisation is Rs 53,617.37 Cr, which places the stock well above the benchmark median in its industry.
- Gland Pharma Stock News remains relevant because the verified price event has no company-specific catalyst attached to it.
About Gland Pharma
Gland Pharma Share Price belongs to a company in the Healthcare sector and the Pharmaceuticals & Drugs industry. Gland Pharma Ltd. operates in injectable formulations and related pharmaceutical work, which places it in a specialised part of the Indian healthcare chain. That business profile matters for Gland Pharma Share Price Today because the market often assesses the company through its product focus, operating execution and valuation ratios rather than through a broad consumer-style lens.
In Gland Pharma Company News terms, the key factual frame is that the company’s listed identity, sector and industry are firmly defined, and its current market capitalisation is Rs 53,617.37 Cr. The stock’s financial profile includes EPS of Rs 74.89, book value of Rs 647.56 and dividend yield of 0.62%. For readers following Gland Pharma Share Price, those figures help anchor the stock within a healthcare company overview, while the sector benchmark shows how it compares with other pharmaceuticals names. That makes Gland Pharma Stock Performance a useful watchpoint across price, valuation and peer context.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).
Frequently Asked Questions
Why is Gland Pharma Share Price rising today?
Ans. Gland Pharma Share Price is higher by 2.05% at Rs 3,295.85. According to latest Univest data, the price event is confirmed, but no company-specific catalyst is established. The previous close was Rs 3,229.8.
What is Gland Pharma Share Price today?
Ans. Gland Pharma Share Price Today is Rs 3,295.85, compared with the previous close of Rs 3,229.80. The move equals Rs 66.05, which keeps the stock in focus for intraday tracking.
What is the market capitalisation of Gland Pharma?
Ans. Gland Pharma has a market capitalisation of Rs 53,617.37 Cr. That size places the company well above the industry median in the benchmark set and gives context to Gland Pharma Share Price movements.
What does Gland Pharma Fundamental Analysis show?
Ans. Gland Pharma Fundamental Analysis shows a P/E of 43.12, P/B of 4.99, ROE of 10.56% and ROCE of 14.96%. EPS is Rs 74.89 and book value is Rs 647.56.
How does Gland Pharma compare with sector benchmarks?
Ans. Gland Pharma Share Price is supported by a P/E above the benchmark median of 30.6 and a P/B above the median of 2.8. Its ROCE of 14.96% is also above the sector median of 13.1%.
How does Gland Pharma compare with peers?
Ans. Gland Pharma Share Price is lower on P/E than Divi’s Laboratories and Torrent Pharmaceuticals, but higher than Lupin, Aurobindo Pharma and Zydus Lifesciences. Its ROE is also below several peers in the set.
What are the key price levels for Gland Pharma today?
Ans. Gland Pharma Share Price traded between Rs 3,227.80 and Rs 3,297.35 today. The stock opened at Rs 3,247.70 and last traded at Rs 3,295.85, which keeps it near the upper end of the range.
Is Gland Pharma a healthcare stock?
Ans. Yes. Gland Pharma Share Price belongs to the Healthcare sector and the Pharmaceuticals & Drugs industry. That classification matters when comparing valuation, returns and company size with other listed drug makers.
Track Gland Pharma Share Price on Univest
Use Gland Pharma Ltd. (GLAND) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.
Gland Pharma Share Price can be tracked on Univest for live price updates, key valuation ratios, 52-week levels and market insights. Readers following Gland Pharma Share Price Today can use Univest to monitor the latest trade, the company’s market cap, and the same ratios that help frame Gland Pharma Stock News and Gland Pharma Stock Analysis throughout the trading day.